サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439256

血液浄化装置 - 世界市場の考察、競合情勢、市場予測（2030年）

Blood Purification Devices/Equipment/Methods - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血液浄化装置 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血液浄化装置の市場規模は、2023年に49億米ドル、2030年までに62億7,000万米ドルに達し、2024年～2030年の予測期間にCAGRで4.19％の成長が見込まれます。血液浄化装置の需要は、主に慢性腎臓病（CKD）と末期腎不全（ESRD）の患者の増加、腎障害につながる高血圧や糖尿病の患者の急増、血液透析の技術の進歩、製品認可の増加、血液浄化装置の採用の増加などによって拡大しています。

血液浄化装置の市場力学

慢性腎臓病（CKD）と末期腎不全（ESRD）の患者の増加は、血液浄化装置市場の主な促進要因の1つです。調査によると、慢性疾患は世界の成人人口の約10%が罹患する傾向にあります。糖尿病、高血圧、血管疾患、糸球体腎炎などの疾患が慢性腎臓病を引き起こすことが知られています。低所得国でも、上記の原因以外に糸球体腎炎と間質性腎炎が慢性腎臓病の主な原因となっています。この調査によると、CKDは特定の年齢層や性別に罹患する傾向がありますが、高齢者の場合はより一般的であり、さまざまな研究により、世界のCKDの有病率は64歳以上で23～36％と推定されています。

上記のデータに加え、International Society of Nephrologyは、2022年に世界で8億5,000万人が何らかの腎臓病を患っていると発表しています。

糖尿病や高血圧など、慢性腎臓病を引き起こす危険因子の増加は、血液浄化装置の需要拡大を後押ししています。International Diabetes Federation（2021）が発表したデータによると、2021年に20～79歳の成人約5億3,700万人が糖尿病を患っています。

しかし、血液浄化装置の高いコストと血液浄化処置に伴うリスクが、予測期間の市場成長を制限する見込みです。

血液浄化装置市場のセグメント分析

血液浄化装置市場のタイプセグメントでは、ポータブル血液浄化装置カテゴリが市場最大の成長セグメントになると予測されています。その理由は、ポータブルタイプの血液浄化装置によって提供される利点、例えば、スペースの利用が少なくて済むことや、特に重症治療室における装置の移動に関連する容易さなどです。そのため、これらは患者の治療に向けて医療従事者に好まれる可能性が高いです。

ポータブル血液浄化装置は、透析を受けながらも日常生活を継続できるようにし、また食事や水分の制限を緩めたり、完全に取り除いたり、錠剤の負担を軽減したりすることで、患者の生活の質を向上させる可能性があります。例えば2022年3月12日、BaxterはAK 98血液透析装置の米国FDA承認を発表しました。この新技術は、透析の提供者にコンパクトで持ち運べる使いやすいシステムを提供します。この装置は、濃縮液や携帯用逆浸透膜の保管や輸送が容易な安定したベースデザインとなっています。このような装置が承認されたことにより、固定型の血液浄化装置と比較してよりよい結果が得られる傾向にあることから、ポータブル装置の需要は今後増加すると予測されます。このことがポータブル血液浄化装置市場の成長につながります。

北米が血液浄化装置市場全体を独占すると予測されます。

すべての地域の中で、北米が血液浄化装置市場で最大のシェアを占めると推定されます。この優位性は、腎臓疾患の有病率の上昇、肥満や高血圧などの生活習慣病の患者人口の増加によるものです。さらに、製品開発活動への広範な取り組みと在宅透析装置の人気の高まりが、北米地域における製品需要をさらに促進すると予測されます。上記の要因に加え、新製品の発売や承認、米国に特化した処置費用の広いカバー範囲が、北米の血液浄化装置市場をさらに押し上げると予測されます。

米国疾病予防管理センターが引用したデータ（2023）によると、米国では成人の約15％が慢性腎臓病を患っていると推定されています。さらに推計によると、女性は男性に比べてCKDの罹患率がやや高いです。CKDは時間の経過とともに腎不全に進行し、透析が必要となります。したがって、患者人口の増加によって示される腎臓疾患の負担の増大は、生命維持療法として透析を必要とする潜在的な患者人口の存在に相当し、したがって国内の製品需要にプラスの影響を与えます。

当レポートでは、世界の血液浄化装置市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 血液浄化装置レポートのイントロダクション

第2章 血液浄化装置のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 血液浄化装置の主な要因の分析

  • 血液浄化装置市場の促進要因
    • 慢性腎臓病（CKD）と末期腎疾患（ESRD）の患者の増加
    • 腎障害を引き起こす高血圧や糖尿病の患者の急増
    • 血液透析における技術の進歩
  • 血液浄化装置市場の抑制要因と課題
    • 血液浄化装置の高いコスト
    • 血液浄化処置に伴うリスク
  • 血液浄化装置市場の機会
    • 血液浄化装置はさまざまな分野で応用されている

第5章 血液浄化装置のポーターのファイブフォース分析

第6章 血液浄化装置市場のレイアウト

  • 製品タイプ別
    • 血液透析装置
    • 血液ろ過装置
    • 持続的腎代替療法（CRRT）装置
    • 血液灌流装置
    • 血漿交換装置
  • タイプ別
    • 固定型
    • 携帯型
  • エンドユーザー別
    • 病院
    • 診断センター
    • その他
  • 地域別
    • 北米の血液浄化装置の市場規模（2021年～2030年）
    • 欧州の血液浄化装置の市場規模（2021年～2030年）
    • アジア太平洋の血液浄化装置の市場規模（2021年～2030年）
    • その他の地域の血液浄化装置の市場規模（2021年～2030年）

第7章 血液浄化装置の企業と製品のプロファイル

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Fresenius SE and Co. KGaA
  • Baxter International Inc.
  • Infomed SA
  • Jafron Biomedical Co., Ltd.
  • Kaneka Corporation
  • Nikkiso Co, ltd.
  • SWS Medical Group
  • Medtronic, Inc.
  • CytoSorbents Europe GmbH
  • Spectral Medical Inc
  • Haemonetics Corporation
  • Ceus Corporation
  • ExThera Medical Corporation

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Blood Purification Devices Market in Global (2021-2030)
  • Table 3: Blood Purification Devices Market in Global by Type (2021-2030)
  • Table 4: Blood Purification Devices Market in Global by Product Type (2021-2030)
  • Table 5: Blood Purification Devices Market in Global by End-User (2021-2030)
  • Table 6: Blood Purification Devices Market in Global by Geography (2021-2030)
  • Table 7: Blood Purification Devices Market in North America (2021-2030)
  • Table 8: Blood Purification Devices Market in the US (2021-2030)
  • Table 9: Blood Purification Devices Market in Canada (2021-2030)
  • Table 10: Blood Purification Devices Market in Mexico (2021-2030)
  • Table 11: Blood Purification Devices Market in Europe (2021-2030)
  • Table 12: Blood Purification Devices Market in France (2021-2030)
  • Table 13: Blood Purification Devices Market in Germany (2021-2030)
  • Table 14: Blood Purification Devices in the United Kingdom (2021-2030)
  • Table 15: Blood Purification Devices Market in Italy (2021-2030)
  • Table 16: Blood Purification Devices Market in Spain (2021-2030)
  • Table 17: Blood Purification Devices Market in Rest of Europe (2021-2030)
  • Table 18: Blood Purification Devices in Asia-Pacific (2021-2030)
  • Table 19: Blood Purification Devices Market in China (2021-2030)
  • Table 20: Blood Purification Devices Market in Japan (2021-2030)
  • Table 21: Blood Purification Devices Market in India (2021-2030)
  • Table 22: Blood Purification Devices Market in Australia (2021-2030)
  • Table 23: Blood Purification Devices Market in South Korea (2021-2030)
  • Table 24: Blood Purification Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Blood Purification Devices Market in the Rest of the World (2021-2030)
  • Table 26: Blood Purification Devices Market in the Middle East (2021-2030)
  • Table 27: Blood Purification Devices Market in Africa (2021-2030)
  • Table 28: Blood Purification Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Blood Purification Devices Market in Global (2021-2030)
  • Figure 3: Blood Purification Devices Market in Global by Type (2021-2030)
  • Figure 4: Blood Purification Devices Market in Global by Product Type (2021-2030)
  • Figure 5: Blood Purification Devices Market in Global by End-User (2021-2030)
  • Figure 6: Blood Purification Devices Market in Global by Geography (2021-2030)
  • Figure 7: Blood Purification Devices Market in North America (2021-2030)
  • Figure 8: Blood Purification Devices Market in the US (2021-2030)
  • Figure 9: Blood Purification Devices Market in Canada (2021-2030)
  • Figure 10: Blood Purification Devices Market in Mexico (2021-2030)
  • Figure 11: Blood Purification Devices Market in Europe (2021-2030)
  • Figure 12: Blood Purification Devices Market in France (2021-2030)
  • Figure 13: Blood Purification Devices Market in Germany (2021-2030)
  • Figure 14: Blood Purification Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Blood Purification Devices Market in Italy (2021-2030)
  • Figure 16: Blood Purification Devices Market in Spain (2021-2030)
  • Figure 17: Blood Purification Devices Market in Rest of Europe (2021-2030)
  • Figure 18: Blood Purification Devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Blood Purification Devices Market in China (2021-2030)
  • Figure 20: Blood Purification Devices Market in Japan (2021-2030)
  • Figure 21: Blood Purification Devices Market in India (2021-2030)
  • Figure 22: Blood Purification Devices Market in Australia (2021-2030)
  • Figure 23: Blood Purification Devices Market in South Korea (2021-2030)
  • Figure 24: Blood Purification Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Blood Purification Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Blood Purification Devices Market in the Middle East (2021-2030)
  • Figure 27: Blood Purification Devices Market in Africa (2021-2030)
  • Figure 28: Blood Purification Devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0044

Blood Purification Devices Market By Product Type (Hemodialysis Device, Blood Filtration Device, Continuous Renal Replacement Therapy (CRRT) Device, Hemoperfusion Device, and Plasma Exchange Device), Type (Portable And Stationary), Application (Diagnostics and Therapeutics) End-User (Hospitals, Dialysis Centres and Others), and Geography is expected to grow at a steady CAGR Forecast till 2030 owing to an Increase In the number of cases for hypertension and the rise observed in the chronic kidney disease (CKD) and end-stage renal disease patients

The global blood purification devices market was valued at USD 4.90 billion in 2023, growing at a CAGR of 4.19% during the forecast period from 2024 to 2030, to reach USD 6.27 billion by 2030. The demand for blood purification devices is primarily witnessing growth on account of the increase in the number of Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) patients, the surge in the cases of hypertension and diabetes leading to kidney disorders, technological advancements in hemodialysis, increasing product approvals, and increase in adoption of blood purification equipment.

Blood Purification Devices Market Dynamics:

The rising number of patients suffering from Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) is one of the major reasons for driving the Blood Purification Devices market. As per research studies, chronic disease tends to affect about 10% of the world's adult population. Several conditions comprising diabetes, hypertension, vascular disease, and glomerulonephritis are known to cause chronic renal disease. Even in low-income countries, besides the above-known causes, glomerulonephritis and interstitial nephritis are the major cause of most chronic kidney disease cases. According to this research, although CKD tends to affect certain age groups and sexes, it is more prevalent in the case of aged individuals, and various studies have estimated that the worldwide prevalence of CKD is 23-36% in people aged >=64.

In addition to the above data, the International Society of Nephrology stated that, worldwide, 850 million people were living with some form of kidney disease in 2022.

The increasing number of risk factors including diabetes, hypertension, and others associated with causing chronic kidney disease are going to assist in the growing demand for blood purification devices. The data published by International Diabetes Federation 2021 stated that around 537 million adults aged between 20 and 79 years were suffering from diabetes in 2021.

However, the high cost of blood purification equipment and the risks associated with blood purification procedures are expected to limit the market growth over the forecast period.

Blood Purification Devices Market Segment Analysis:

Blood Purification Devices Market by Product Type (Hemodialysis Device, Blood Filtration Device, Continuous Renal Replacement Therapy (CRRT) Device, Hemoperfusion Device, and Plasma Exchange Device), Type (Portable and Stationary), Application (Diagnostics and Therapeutics), End-User (Hospitals, Dialysis Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type segment of the blood purification devices market, the portable blood purification devices category is anticipated to be the largest growing segment in the market. The reason is the advantages that are offered by the portable type of blood purification devices such as less utilization of space and ease related to movement of the devices, specifically in critical care units. Therefore, these are most likely preferred by healthcare professionals for the treatment of patients.

Portable blood purification devices can potentially improve the quality of patient life by allowing them to continue with their daily activities of life while undergoing dialysis as well as by loosening-or removing entirely-dietary and fluid restrictions and reducing pill burden. For instance, on March 12, 2022, Baxter announced the US FDA approval of the AK 98 Hemodialysis Machine. The latest technology provides a compact, portable, and easy-to-use system for dialysis providers. The machine has a stable base design which allows for easy concentrate or portable reverse osmosis storage and transportation of the machine. Due to the approval of such devices, the demand for portable devices is expected to rise in the future as they tend to offer better results in comparison to stationary blood purification devices. This will lead to the growth of the portable blood purification devices market.

North America is expected to dominate the overall Blood Purification Devices Market:

Among all the regions, North America is estimated to account for the largest share of the blood purification devices market. This domination is due to the rising prevalence of kidney disorders, and the rising population of patients suffering from lifestyle disorders such as obesity and hypertension. Moreover, extensive efforts in product developmental activities and the growing popularity of home-based dialysis devices are further expected to drive product demand in the North American region. In addition to the above-stated factors, the new product launches and approvals and the extensive coverage of procedural costs specifically in the United States are expected to further boost the market for blood purification devices in North America.

As per the data cited by the Centers for Disease Control and Prevention (2023), about 15% of adults in the United States (accounting for approximately 37 million people) are estimated to have chronic kidney disease. According to further estimates presented by the source, women are slightly more affected by CKD as compared to men. CKD, over time, progresses to kidney failure thereby necessitating the need for dialysis. Therefore, the growing burden of kidney disorders indicated by the increase in patient population corresponds to the presence of a potential patient population that may require dialysis as a life-supporting therapy, thus positively influencing the product demand in the nation.

Additionally, another key factor that is thought to contribute to the increasing prevalence of kidney disorders is the surge in obesity in the country's population. For instance, as per the data provided by the CDC (2023), in 2017-2018, the obesity prevalence in the country was 42.4%. Obesity has been established as a formidable risk factor for the development of kidney disease. It has been studied that in patients affected by obesity, a compensatory mechanism of hyperfiltration is said to take place to meet the increased metabolic demands due to a gain in body weight. This can massively increase the intraglomerular pressure which may damage the kidney structure and escalate the risk of developing CKD in the long term.

Thus, the interplay of all the previous factors is likely to contribute to the market growth of blood purification devices in the United States as well as the North America region as a whole during the forecast period.

Blood Purification Devices Market Key Players:

Some of the key market players operating in the blood purification devices market include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE and Co. KGaA, Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, Nikkiso Co, ltd. and SWS Medical Group, CytoSorbents Europe GmbH, Spectral Medical Inc., Haemonetics Corporation, Medtronic, Cerus Corporation, ExThera Medical Corporation and others.

Blood Purification Devices Market Recent Developmental Activities:

In December 2022, Medtronic launched the first neonatal dialysis machine in the US.

In June 2022, the New York-based startup, Qidni Labs, a company pursuing waterless and mobile blood purification systems, announced that they are looking forward to human trials in 2022 following a successful animal study.

In March 2022, Baxter received FDA clearance for its latest, portable dialysis machine designed to connect directly with electronic medical records for patients' prescriptions and treatment data.

Key Takeaways from the Blood Purification Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global blood purification devices market.

Various opportunities available for the other competitor in the blood purification devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for market growth in the coming future?

Target Audience who can be benefited from this Blood Purification Devices Market Report Study

Blood Purification Devices providers

Research organizations and consulting companies

Blood Purification Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders

Various End-users who want to know more about the blood purification devices market and the latest technological developments in the blood purification devices market.

Frequently Asked Questions for Blood Purification Devices Market:

1. What are Blood Purification Devices?

Blood Purification is a procedure that involves the withdrawal of blood from the patient's body into a device or equipment to eliminate the impurities and pump them back into the body. The blood purification devices are similar to that of dialysis equipment. These devices use thin fibers for capturing and removing viruses and help in filtering blood.

2. What is the market for global blood purification devices?

The global blood purification devices market was valued at USD 4.90 billion in 2023, growing at a CAGR of 4.19% during the forecast period from 2024 to 2030, to reach USD 6.27 billion by 2030.

3. What are the drivers for global blood purification devices?

The major drivers driving the demand for global blood purification devices are the increase in the number of chronic kidney disease and end-stage renal disease patients, the increasing number of cases of hypertension and diabetes leading to kidney disorders, technological advancements in hemodialysis, the rise in the number of product approvals by FDA and increase in adoption of blood purification equipment.

4. Who are the key players operating in the global blood purification devices?

Some of the key market players operating in the blood purification devices market include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE and Co. KGaA, Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, and others.

5. Which region has the highest share in the blood purification devices market?

North America is expected to dominate the overall blood purification devices during the forecast period, 2024 to 2030. This domination is due to the rising prevalence of CKD and ESRD in patients along with the increased awareness regarding blood purification devices and the rapid expansion of healthcare infrastructure.

Table of Contents

1. Blood Purification Devices Report Introduction

2. Blood Purification Devices Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Blood Purification Devices Key Factors Analysis

  • 4.1. Blood Purification Devices Market Drivers
    • 4.1.1. Increase in number of Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) patients
    • 4.1.2. Surge in the cases of hypertension and diabetes leading to kidney disorders
    • 4.1.3. Technological advancements in hemodialysis
  • 4.2. Blood Purification Devices Market Restraints and Challenges
    • 4.2.1. High cost of blood purification devices
    • 4.2.2. Risks associated with the blood purification procedures
  • 4.3. Blood Purification Devices Market Opportunities
    • 4.3.1. Blood Purification Devices have applications in various domains

5. Blood Purification Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Blood Purification Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Hemodialysis Device
    • 6.1.2. Blood Filtration Device
    • 6.1.3. Continuous Renal Replacement Therapy (CRRT) Device
    • 6.1.4. Hemoperfusion Device
    • 6.1.5. Plasma Exchange Device
  • 6.2. By Type
    • 6.2.1. Stationary
    • 6.2.2. Portable
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Diagnostic Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Blood Purification Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.1. France Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Blood Purification Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.1. China Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Blood Purification Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Blood Purification Devices Market Size in USD million (2021-2030)

7. Blood Purification Devices Company and Product Profiles

  • 7.1. Asahi Kasei Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. B. Braun Melsungen AG
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Fresenius SE and Co. KGaA
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Baxter International Inc.,
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Infomed SA
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Jafron Biomedical Co., Ltd.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Kaneka Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Nikkiso Co, ltd.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. SWS Medical Group
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Medtronic, Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. CytoSorbents Europe GmbH
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Spectral Medical Inc
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Haemonetics Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Ceus Corporation
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. ExThera Medical Corporation
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us